Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000567482 | SCV000664815 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-04-03 | criteria provided, single submitter | clinical testing | The c.3659_3662delATTCinsG variant (also known as p.Y1220_S1221delinsC), located in coding exon 10 of the BRCA2 gene, results from an in-frame deletion of ATTC and insertion of G at nucleotide positions 3659 to 3662. This results in the substitution of the tyrosine and serine residues for a cysteine residue at codon 1220. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |